Loading Nifty 50, Nifty Bank, and Sensex…
Advanced Enzyme Technologies Limited
ADVENZYMES · Corporate filings
NSE
Advanced Enzyme Technologies Limited
ADVENZYMES · NSE · Healthcare
₹284.10
0.21%
As of 12 Nov 2026
Advanced Enzyme Technologies Limited (ADVENZYMES) is listed on NSE in the Healthcare sector. It last traded at ₹284.10, up 0.21% on the session. Its 52-week range is ₹246.80 to ₹419.00.
Research output is rule-based and informational only. It is not investment advice.
Analytics for ADVENZYMES are not available yet. Technicals, fundamentals, peer ranking
and risk notes appear here once this listing's daily history and annual filings are synced.
Financial Charts & Report
Stock market charts for Advanced Enzyme Technologies Limited quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.
Loading financial charts...
Results Change Summary quarter-on-quarter and year-on-year filing evidence
Generate an evidence-linked summary of revenue, margin, profit, debt, cash and operating cash flow changes.
Financial Results figures in ₹ crore, except EPS/%
Loading…
Relative Returns stock, sector, and exchange benchmarks
Loading…
CAN SLIM William O'Neil's growth-stock criteria
Loading…
Latest Shareholding Pattern promoter, FII, DII, public and institution trend
Corporate Governance SEBI integrated governance filing
Loading governance disclosure...
Announcements
Announcement
SAST disclosures
Announcement
Announcement
Announcement
Announcement
SAST disclosures
Announcement
Announcement
Announcement
Market activity
Short selling - 1 shares
SAST disclosures
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
Full history
Dividend
Dividend - Rs 1.35 Per Share Dividend - Rs 1.35 Per Share
Ex-date: 24 Jul 2026
Dividend
Dividend - Rs 1.20 Per Share Dividend - Rs 1.20 Per Share
Ex-date: 23 Jul 2025
Dividend
Interim Dividend - Rs 4 Per Share Interim Dividend - Rs 4 Per Share
Ex-date: 16 May 2025
Dividend
Dividend - Re 1.1 Per Share Dividend - Re 1.1 Per Share
Ex-date: 18 Jul 2024
Dividend
Interim Dividend - Rs 4 Per Share Interim Dividend - Rs 4 Per Share
Ex-date: 17 May 2024
Dividend
Dividend - Re 1 Per Share Dividend - Re 1 Per Share
Ex-date: 04 Aug 2023
Dividend
Interim Dividend - Rs 4 Per Share Interim Dividend - Rs 4 Per Share
Ex-date: 19 May 2023
Dividend
Dividend - Re 1 Per Share Dividend - Re 1 Per Share
Ex-date: 11 Aug 2022
Dividend
Dividend - Rs 0.90 Per Share Dividend - Rs 0.90 Per Share
Ex-date: 31 Aug 2021
Dividend
Annual General Meeting/Dividend - Rs 0.60 Per Share Annual General Meeting/Dividend - Rs 0.60 Per Share
Ex-date: 09 Jul 2020
Dividend
Annual General Meeting/Dividend - Rs 0.60 Per Share Annual General Meeting/Dividend - Rs 0.60 Per Share
Ex-date: 01 Aug 2019
Dividend
Annual General Meeting/Dividend Re 0.50 Per Share Annual General Meeting/Dividend Re 0.50 Per Share
Ex-date: 06 Sep 2018
Dividend
Annual General Meeting/Dividend - Re 0.40 Per Share(Book Closure Dates Revised) Annual General Meeting/Dividend - Re 0.40 Per Share(Book Closure Dates Revised)
Ex-date: 04 Sep 2017
Split
Face Value Split From Rs 10/- Per Share To Rs 2/- Per Share Face Value Split From Rs 10/- Per Share To Rs 2/- Per Share
Ex-date: 25 May 2017
Other
Annual General Meeting Annual General Meeting
Ex-date: 08 Sep 2016
Board Meetings
31 Oct 2026
The Board of Directors at their meeting held today i.e. October 31, 2026 have analyzed the requests received from the promoter group members for their reclassification from promoter group category to public category shareholders, pursuant to Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended
31 Oct 2026
Advanced Enzyme Technologies Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
08 Aug 2026
Advanced Enzyme Technologies Limited has informed the Exchange regarding Outcome of Board Meeting held on August 08, 2026.
08 Aug 2026
Advanced Enzyme Technologies Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
09 May 2026
The Board has decided to defer the declaration of an interim dividend. While the Company continues to maintain a healthy financial position and robust liquidity, the Board intends to preserve capital as of now to provide necessary flexibility to the Company to evaluate other potential strategic avenues / corporate actions which can maximize long-term shareholder value. The Board may evaluate this at an appropriate time and the decision, if any, thereon shall be intimated by the Company to the Stock Exchange(s).
09 May 2026
The Board has decided to defer the declaration of an interim dividend. While the Company continues to maintain a healthy financial position and robust liquidity, the Board intends to preserve capital as of now to provide necessary flexibility to the Company to evaluate other potential strategic avenues / corporate actions which can maximize long-term shareholder value. The Board may evaluate this at an appropriate time and the decision, if any, thereon shall be intimated by the Company to the Stock Exchange(s).
09 May 2026
Advanced Enzyme Technologies Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.